|
Status |
Public on Mar 07, 2021 |
Title |
miRNA-seq of glioma patient tissues treated by DMSO or LY2109761 |
Organism |
Homo sapiens |
Experiment type |
Non-coding RNA profiling by high throughput sequencing
|
Summary |
Glioma tissues from patients were cultured in complete DMEM and treated with either DMSO or LY2109761, an inhibitor of TGFBR2. Tissue blocks of TBD0207 and TBD0220 were subjected to miRNA-seq.
|
|
|
Overall design |
Examination of differential expressive genes in glioma tissues treated by DMSO or LY2109761 from patients.
|
|
|
Contributor(s) |
Wang Q, Cai J, Zhang J, Kang C |
Citation(s) |
30279734 |
|
Submission date |
Mar 12, 2018 |
Last update date |
Jun 07, 2021 |
Contact name |
Jinquan Cai |
E-mail(s) |
caijinquan666777@126.com
|
Organization name |
Harbin Medical University
|
Street address |
Xuefu Road
|
City |
Harbin |
ZIP/Postal code |
150086 |
Country |
China |
|
|
Platforms (1) |
|
Samples (4)
|
|
This SubSeries is part of SuperSeries: |
GSE111676 |
Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-Beta pathway |
|
Relations |
BioProject |
PRJNA437874 |
SRA |
SRP134912 |